nkarta Inc.

27/06/2024 | Press release | Distributed by Public on 27/06/2024 21:04

Nkarta Initiates Clinical Trial of NKX019 in Lupus Nephritis with First Patient in Screening and Announces Pipeline Expansion to Additional Autoimmune Indications